1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Intestinal Cancer Global Clinical Trials Review, H1, 2015

Intestinal Cancer Global Clinical Trials Review, H1, 2015

  • February 2015
  • -
  • Global Data
  • -
  • 247 pages

Intestinal Cancer Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Intestinal Cancer Global Clinical Trials Review, H1, 2015" provides data on the Intestinal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Intestinal Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Intestinal Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Intestinal Cancer Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Intestinal Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Intestinal Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Intestinal Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Intestinal Cancer 25
Subjects Recruited Over a Period of Time 50
Clinical Trials by Sponsor Type 51
Prominent Sponsors 52
Top Companies Participating in Intestinal Cancer Therapeutics Clinical Trials 53
Prominent Drugs 54
Clinical Trial Profiles 55
Clinical Trial Overview of Top Companies 55
F. Hoffmann-La Roche Ltd. 55
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 55
Sanofi 73
Clinical Trial Overview of Sanofi 73
Pfizer Inc. 82
Clinical Trial Overview of Pfizer Inc. 82
Amgen Inc. 88
Clinical Trial Overview of Amgen Inc. 88
Novartis AG 93
Clinical Trial Overview of Novartis AG 93
Bristol-Myers Squibb Company 97
Clinical Trial Overview of Bristol-Myers Squibb Company 97
AstraZeneca PLC 101
Clinical Trial Overview of AstraZeneca PLC 101
E. Merck KG 105
Clinical Trial Overview of E. Merck KG 105
Otsuka Holdings Co., Ltd. 109
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 109
Bayer AG 112
Clinical Trial Overview of Bayer AG 112
Clinical Trial Overview of Top Institutes / Government 115
National Cancer Institute 115
Clinical Trial Overview of National Cancer Institute 115
Memorial Sloan Kettering Cancer Center 131
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 131
University of Texas M. D. Anderson Cancer Center 135
Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center 135
European Organization for Research and Treatment of Cancer 138
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 138
Sun Yat-sen University 141
Clinical Trial Overview of Sun Yat-sen University 141
FUDAN University 143
Clinical Trial Overview of FUDAN University 143
Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group 145
Clinical Trial Overview of Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group 145
Cancer Research UK 147
Clinical Trial Overview of Cancer Research UK 147
City of Hope 149
Clinical Trial Overview of City of Hope 149
NCIC Clinical Trials Group 151
Clinical Trial Overview of NCIC Clinical Trials Group 151
Five Key Clinical Profiles 153
Appendix 244
Abbreviations 244
Definitions 244
Research Methodology 245
Secondary Research 245
About GlobalData 246
Contact Us 246
Disclaimer 246
Source 247

List of Tables
Intestinal Cancer Therapeutics, Global, Clinical Trials by Region, 2015* 7
Intestinal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Intestinal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Intestinal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Intestinal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Intestinal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Intestinal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Intestinal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Intestinal Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Intestinal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Intestinal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Intestinal Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Intestinal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Intestinal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Intestinal Cancer Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Intestinal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Intestinal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Intestinal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Intestinal Cancer Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Intestinal Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2015* 27
Intestinal Cancer Therapeutics, Global, Terminated Clinical Trials, 2015* 31
Intestinal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 50
Intestinal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 51
Intestinal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 52
Intestinal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 53
Intestinal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 54
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 55
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 73
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 82
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015* 88
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 93
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 97
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 101
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2015* 105
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015* 109
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 112
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 115
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 131
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2015* 135
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015* 138
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015* 141
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2015* 143
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group, 2015* 145
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Research UK, 2015* 147
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope, 2015* 149
Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by NCIC Clinical Trials Group, 2015* 151

List of Figures
Intestinal Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Intestinal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Intestinal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Intestinal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Intestinal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Intestinal Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Intestinal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Intestinal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Intestinal Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Intestinal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Intestinal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Intestinal Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Intestinal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Intestinal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Intestinal Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Intestinal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Intestinal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Intestinal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Intestinal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 50
Intestinal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 51
Intestinal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 52
Intestinal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 53
Intestinal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 54
GlobalData Methodology 245

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.